Infinimmune is a seed startup based in United States. 2 investors tracked.
Infinimmune is a company founded in 2019 headquartered in the United States. Its most recent tracked round is Seed. Brouky records 2 investors associated with the company.
A biotechnology company that discovers human-derived antibodies for therapeutic use, leveraging the power of the human immune system to identify promising drug candidates.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.